Ligand Pharmaceuticals | LGND - EPS Earnings Per Share


Ligand Pharmaceuticals reported $1.63 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 2.54 3.09 Nov/05
FY2026Q2 Jun/2026 1.95 1.60 Aug/11
FY2026Q1 Mar/2026 1.63 1.82 1.33 May/07
FY2025Q4 Dec/2025 2.02 1.49 1.27 Feb/26
FY2025Q3 Sep/2025 3.09 1.93 1.84 Nov/06




Eps Change Date
Agenus USD 1.02 1.32 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD -0.93 1.15 Mar/2026
Baxter International USD 0.36 0.08 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Enviri Corporation USD -1.02 0.92 Dec/2025
Gilead Sciences USD 2.03 0.17 Mar/2026
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Glaxosmithkline GBP 0.62 0.41 Mar/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Insmed USD -0.76 0.78 Mar/2026
Intrexon USD -0.1 0.03 Jun/2024
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
Ligand Pharmaceuticals USD 1.63 0.39 Mar/2026
MacroGenics USD -0.58 0.36 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Pacira USD 0.6 0.54 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Veracyte USD 0.52 0.01 Mar/2026